China National Medicines Corporation Ltd. (600511.SS) reported a profit for its first quarter that Increased, from the same period last year
The company's earnings totaled RMB474.263 million, or RMB0.6286 per share. This compares with RMB459.015 million, or RMB0.6084 per share, last year.
The company's revenue for the period rose 6.6% to RMB13.555 billion from RMB12.713 billion last year.
China National Medicines Corporation Ltd. earnings at a glance (GAAP) :
-Earnings: RMB474.263 Mln. vs. RMB459.015 Mln. last year.-EPS: RMB0.6286 vs. RMB0.6084 last year.-Revenue: RMB13.555 Bln vs. RMB12.713 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.